Cleared Traditional

K243782 - StimTrial Neuromodulation System
(FDA 510(k) Clearance)

K243782 · Bioventus, LLC · Neurology
Jul 2025
Decision
219d
Days
Class 2
Risk

K243782 is an FDA 510(k) clearance for the StimTrial Neuromodulation System. This device is classified as a Stimulator, Peripheral Nerve, Implanted (pain Relief) (Class II — Special Controls, product code GZF).

Submitted by Bioventus, LLC (Durham, US). The FDA issued a Cleared decision on July 16, 2025, 219 days after receiving the submission on December 9, 2024.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5870.

Submission Details

510(k) Number K243782 FDA.gov
FDA Decision Cleared SESE
Date Received December 09, 2024
Decision Date July 16, 2025
Days to Decision 219 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZF — Stimulator, Peripheral Nerve, Implanted (pain Relief)
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5870

Similar Devices — GZF Stimulator, Peripheral Nerve, Implanted (pain Relief)

All 23
TalisMann Neuromodulation System
K243678 · Bioventus, LLC · Jul 2025
Nalu Neurostimulation System for Peripheral Nerve Stimulation
K232415 · Boston Scientific Neuromodulation · Aug 2024
Freedom Peripheral Nerve Stimulator (PNS) System
K233162 · Curonix · Jun 2024
Neuspera Nuity System
K221303 · Neuspera Medical, Inc. · Apr 2023
StimRouter Neuromodulation System
K211965 · Bioness, Inc. · Feb 2022
Neuspera Neurostimulation System (NNS)
K202781 · Neuspera Medical, Inc. · Aug 2021